Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model-Reference-Cited by-同舟云学术

Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model

Published:2021-05 Issue:5 Volume:57 Page:106330
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Hagihara Mao,Kato Hideo,Sugano Toshie^ORCID,Okade Hayato^ORCID,Sato Nobuo^ORCID,Shibata Yuichi,Sakanashi Daisuke,Asai Nobuhiro,Koizumi Yusuke,Suematsu Hiroyuki,Yamagishi Yuka,Mikamo Hiroshige

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference35 articles.

1. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study;van Duin;Lancet Infect Dis,2020

2. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace;Logan;J Infect Dis,2017

3. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study;Kumarasamy;Lancet Infect Dis,2010

4. Evolution of IncA/C blaCMY-₂-carrying plasmids by acquisition of the blaNDM-₁ carbapenemase gene;Carattoli;Antimicrob Agents Chemother,2012

5. Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan;Yamamoto;J Hosp Infect,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapies in preclinical and in early clinical development for the treatment of urinary tract infections: from pathogens to therapies;Expert Opinion on Investigational Drugs;2024-05-09

2. Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations;Antibiotics;2024-04-07

3. Review on Characterization, Properties, and Analytical Methods of Cefepime;International Journal of Analytical Chemistry;2022-06-29

4. Innovative β-lactam/β-lactamase inhibitor combinations for carbapenem-resistant Gram-negative bacteria;Future Microbiology;2022-04

5. Global Threat of Carbapenem-Resistant Gram-Negative Bacteria;Frontiers in Cellular and Infection Microbiology;2022-03-15